Tag Archives: Coronavirus

U.S. government to ship COVID-19 vaccines directly to community health centers starting next week

(Reuters) – The U.S. government will begin shipping COVID-19 vaccines directly to community health centers around the country next week in an effort to speed vaccination and ensure doses are reaching vulnerable populations, U.S. health officials said on Tuesday.

It will begin by shipping doses to 250 centers nationwide selected based on their proximity to vulnerable groups, such as homeless people and those with limited proficiency in English, they said, but will eventually scale to 1400 community health centers in the United States.

(Reporting by Carl O’Donnell; Editing by Chris Reese)

Britain tightens travel restrictions with hotel quarantine and prison threat

By Sarah Young

LONDON (Reuters) – Britain will require passengers arriving from countries where worrying coronavirus variants are spreading to pay for 10 days of quarantine in hotels, while rule-breakers will face heavy fines or jail terms, under tighter restrictions from next week.

The new travel rules add to restrictions that already ban travel abroad for holidays. The government said the stronger measures were needed to prevent new variants of the virus from thwarting Britain’s rapid vaccination program.

Airlines and travel companies called for more government aid, saying the new rules would deepen a crisis that has seen them lose nearly all their revenue.

Health secretary Matt Hancock said people could be sent to prison and fined up to 10,000 pounds ($14,000) if they break the rules which come into force on Feb. 15.

“Anyone who lies on the passenger locator form and tries to conceal that they’ve been in a country on the ‘red list’ in the 10 days before arrival here, will face a prison sentence of up to 10 years,” Hancock told parliament.

British and Irish nationals arriving in England who have been in high risk countries in the last 10 days would be required to pay 1,750 pounds ($2,400) to cover the cost of a minimum 10-day quarantine in a designated hotel, Hancock said.

All arrivals into the UK will also have to take further COVID-19 tests on day 2 and day 8 of their quarantines, he said, on top of a pre-departure test already required.

Britain has rolled out the fastest vaccination program of any large country. But there has been alarm in recent days after reports that the vaccines it is using may be less effective against some new variants of the virus, such as one that has spread rapidly in South Africa.

NO END IN SIGHT

The government, criticized in recent weeks for being slow to bring in tougher border measures, said the stricter rules could stay in place until it is sure vaccines work against new variants, or booster shots become available.

“Strong protections at the border are part of defending and safely allowing the domestic opening up,” Hancock said.

British airlines and airports issued a new cry for help, the latest of many, urging the government to provide more support to make sure the sector makes it through the year, and to issue a roadmap on how it will ease restrictions.

“Airports and airlines are battling to survive with almost zero revenue and a huge cost base, and practically every week a further blow lands,” aviation trade bodies said.

Hancock said the measures could not be in place permanently and would be replaced “over time with a system of safe and free international travel”.

The government said it had contracted 16 hotels for an initial 4,600 rooms for hotel quarantine and would secure more as needed, with further details due to be published on Thursday.

Quarantines in hotels have been used by Australia and New Zealand as a strategy to sharply limit the spread of the coronavirus.

($1 = 0.7259 pounds)

(Reporting by Guy Faulconbridge and Kate Holton, additional reporting by Andrew MacAskill, Editing by Paul Sandle, Michael Holden, Giles Elgood, Peter Graff)

COVID-19 vaccine chasers hunt, wait and hope in Los Angeles

By Norma Galeana

SANTA FE SPRINGS, Calif. (Reuters) – Jose Luis Espinoza had been chasing a COVID-19 vaccine for more than three weeks.

He hadn’t hugged his 98-year-old father in a long time, and was hoping a vaccine would change that. Last week, he struck gold in Santa Fe Springs.

“It was the last dose they gave, and I was the lucky one,” the 68-year-old said.

The chase for leftover vaccine doses is widespread and competitive in Los Angeles. The wait can last for hours outside a clinic or vaccination site, and most people are turned away without a shot.

Clinics have leftover doses when people cancel their appointments at the last minute or don’t show up. Once opened, vaccine vials have an expiry date: 5 days for the Pfizer vaccine and 30 days for the Moderna one.

“We need to make sure if we’re going to pull out that vaccine, that we have the people signed up and the resources and the event scheduled,” said Will Baker, clinic manager for private ambulance service CARE Ambulance, stressing the importance of not wasting any of the precious doses.

‘NEVER GUARANTEED’

Vaccine chasers have been criticized for getting doses when it’s not their turn, perhaps taking it away from someone who might need it more.

“I’m here in the hope that there’s some that might be left over,” said Cynthia Perez, 48, the first to arrive when the Santa Fe Springs clinic opened at 2:00pm.

“So I’m not trying to jump the line. I’m just trying to take advantage of any vaccines or any doses that might be thrown away,” she said.

Perez said she had a child with asthma, and was in ill-health herself, adding, “I’m trying to get ahead of the curve a bit and stay healthy.”

As the evening wore on, the line of chasers outside the clinic grew, and Baker took down their details. Throughout the day, he counted the doses left at each vaccine station, revised the list of appointments, and did the math.

When the clinic closed at 6 p.m., and there was a single shot left over, he called Espinoza’s name.

“I went over the guidelines and I looked for anyone in the line that was 1A,” Baker explained, referring to the first category of vaccine allocation as recommended by the U.S. Centers for Disease Control and Prevention.

“We did have one person in the line that met the 1A criteria and we were able to get him a vaccine today,” he said.

Then Baker went outside and told the rest of the line there were no more doses for the day, apologizing and thanking everyone for their patience.

Perez picked up her bag and headed home, disappointed but not deterred.

“You can’t be upset. It’s never guaranteed,” she said.

(Reporting by Norma Galeana; Editing by Sandra Stojanovic, Karishma Singh and Gerry Doyle)

Biden believes U.S. teachers are priority for vaccinations, White House says

WASHINGTON (Reuters) – President Joe Biden believes America’s teachers should be a priority in getting vaccinated against the coronavirus, but he will listen to scientists’ recommendations on a comprehensive approach to reopening schools, the White House said on Tuesday.

“He believes that teachers should be a priority on the vaccination list – he has supported that,” White House Communications Director Kate Bedingfield said in an interview with MSNBC.

“He believes that teachers should get their vaccines, but he’s listening to the science, and there are a number of important steps that we need to take to ensure that schools can open and open safely,” she said. “Vaccines are one piece of it.”

Official guidance for reopening American schools will likely come later in the week from the U.S. Centers for Disease Control and Prevention (CDC), Bedingfield said.

School reopenings have become a hot topic across the nation. District officials, teachers, parents and health professionals have been debating when and how to safely reopen for millions of students who have been taking classes remotely for 11 months since the pandemic closed schools last spring.

Educators in major cities, including Chicago and Philadelphia, on Monday called for strong COVID-19 safety protocols in their classrooms as those and other districts pushed to reopen.

“There are a number of important steps that we need to take to ensure that schools can open and open safely. Vaccines are one piece of it,” Bedingfield said. “There needs to be masking, there needs to be room for social distancing, so those mitigation measures are just as important.”

(Reporting by Doina Chiacu; Editing by Chizu Nomiyama and Jonathan Oatis)

COVID may have taken ‘convoluted path’ to Wuhan, WHO team leader says

By Josh Horwitz and David Stanway

WUHAN, China (Reuters) – The head of a World Health Organization-led team probing the origins of COVID-19 said bats remain a likely source and that transmission of the virus via frozen food is a possibility that warrants further investigation, but he ruled out a lab leak.

Peter Ben Embarek, who led the team of independent experts in its nearly month-long visit to the Chinese city of Wuhan, where the outbreak first emerged at a seafood market in late 2019, said the team’s work had uncovered new information but had not dramatically changed their picture of the outbreak.

“The possible path from whatever original animal species all the way through to the Huanan market could have taken a very long and convoluted path involving also movements across borders,” Embarek told a nearly three-hour media briefing.

Embarek said work to identify the coronavirus’s origins points to a natural reservoir in bats, but it is unlikely that they were in Wuhan.

Investigators were also looking for Chinese blood samples that could indicate that the virus was circulating earlier than first thought, he said.

“In trying to understand the picture of December 2019 we embarked on a very detailed and profound search for other cases that may have been missed, cases earlier on in 2019,” he said.

“And the conclusion was we did not find evidence of large outbreaks that could be related to cases of COVID-19 prior to December 2019 in Wuhan or elsewhere.”

The possibility the virus leaked from a lab – which has been the subject of conspiracy theories – was extremely unlikely and did not require further study, Embarek said.

Liang Wannian, head of China’s expert panel on the outbreak, said there was evidence of coronavirus infections that could have preceded the first detected case by “several weeks”.

“This suggests that we cannot rule out that it was circulating in other regions and the circulation was unreported,” he told the briefing.

FROZEN ANIMALS?

Embarek said the team had identified market vendors selling frozen animal products including farmed wild animals.

“So there is the potential to continue to follow this lead and further look at the supply chain and animals that were supplied to the market,” he said.

China has pushed the idea that the virus can be transmitted by frozen food and has repeatedly announced findings of coronavirus traces on imported food packaging.

“We know the virus can survive in conditions that are found in these cold, frozen environments, but we don’t really understand if the virus can transmit to humans” or under which conditions, Embarek told the briefing.

The team arrived in Wuhan on Jan. 14 and after two weeks of quarantine, visited key sites including the Huanan seafood market, the location of the first known cluster of infections, as well as the Wuhan Institute of Virology, which has been involved in coronavirus research.

Members of the team sought to rein in expectations for the mission, with infectious disease expert Dominic Dwyer saying it would probably take years to fully understand the origins of COVID-19.

The United States said China needed to be more open when it comes to sharing data and samples as well as allowing access to patients, medical staff and lab workers. Beijing subsequently accused Washington of politicizing a scientific mission.

(Reporting by Josh Horwitz in Wuhan and David Stanway in Shanghai; Additional reporting by Stephanie Nebehay in Geneva; Writing by Tony Munroe; Editing by Raju Gopalakrishnan, Gareth Jones and Nick Macfie)

U.S. COVID-19 cases and hospitalizations log biggest weekly drops since pandemic started

(Reuters) – The United States reported a 25% drop in new cases of COVID-19 to about 825,000 last week, the biggest fall since the pandemic started, although health officials said they were worried new variants of the virus could slow or reverse this progress.

New cases of the virus have now fallen for four weeks in a row to the lowest level since early November, according to a Reuters analysis of state and county reports. The steepest drop was in California, where cases in the week ended Feb. 7 fell 48%. Only Oregon, Puerto Rico, Arkansas and Vermont saw cases rise.

At least three new variants of the novel coronavirus are circulating in the United States, including the UK variant B.1.1.7 that is 30% to 40% more contagious, according to researchers.

“I’m asking everyone to please keep your guard up,” Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said on Monday. “The continued proliferation of variants remains a great concern and is a threat that could reverse the recent positive trends we are seeing.”

The average number of COVID-19 patients in hospitals fell by 15% to 88,000 last week, also a record percentage drop, according to a Reuters analysis of data from the volunteer-run COVID Tracking Project. It was the lowest average number in hospitals since late November.

Death fell 2.5% last week to 22,193. Excluding a backlog of deaths reported by Indiana, fatalities were down 9.5% last week. Deaths are a lagging indicator and usually fall several weeks after cases and hospitalizations drop.

Cumulatively, nearly 464,000 people have died from the virus in the United States, or one in every 704 residents.

Nationally, 7.3% of tests of tests came back positive for the virus, down from 8.5% the prior week, according to data from the COVID Tracking Project.

(Graphic by Chris Canipe, writing by Lisa Shumaker, editing by Tiffany Wu)

One U.S. company’s risky effort to build a new mask factory during COVID

By Timothy Aeppel

LA VERNE, Calif. (Reuters) – Dan Izhaky is betting $4 million that the pandemic will change what Americans are willing to pay for high quality face masks from his new factory here in this suburb of Los Angeles.

It’s a risky wager.

Before COVID-19 hit, the United States imported much of the personal protection equipment needed by health care providers, mainly from Asia. Some U.S. companies pivoted in the crisis, such as liquor companies churning out hand sanitizer and plastics firms making face shields.

But one item that remains in tight supply is N95 face masks, which provide a high level of filtration against airborne contaminants and are closely regulated by the U.S. government.

Izhaky is president of United Safety Technology Inc, a startup that is poised to open a new N95 mask factory possibly within weeks. While the plant is still being fitted with machinery, his goal is to make 1 million masks a day when it’s up and running. Izhaky said if they get approval from regulators soon, the plant could be shipping that amount by the end of the second quarter.

“The big question we face is what happens post-pandemic,” said Izhaky, “when you have a hospital administrator or whoever it is that’s in charge of purchasing” and looking at U.S.-made masks that cost more. The pricing of many types of protective equipment remain elevated by shortages, but once the market normalizes Izhaky estimates his masks will cost about 30% more than Chinese masks, or about $1.15 each.

Other domestic producers are likely to face the same challenge, including industry giants Izhaky will compete with. 3M Co has quadrupled its domestic production of N95 masks since the start of the pandemic, expanding a factory in South Dakota and hiring 300 workers and now makes nearly 100 million masks in the U.S. a month. Honeywell International Inc has opened “multiple new locations in the Phoenix area” to make N95 masks, said spokesman Eric Krantz, and converted a significant portion of a factory in Rhode Island that also makes safety glasses.

Krantz said Honeywell doesn’t view the expansion as a risk.

“We’re confident there will be continued demand for high-quality respiratory protection products,” he said in an email. “We’ve made smart, strategic investments in expanding our N95 production.”

But many smaller producers aren’t so sure.

“China subsidizes their face masks,” so every producer faces a challenge in competing with China after the pandemic, said Vitali Servutas, CEO of AmeriShield, which built a factory that makes single-use surgical masks, not N95 masks, in Virginia last year in response to the crisis.

Izhaky hopes, but is not certain, that the pandemic will make Americans more willing to pay a premium, or that U.S. government policy will mandate more domestic sourcing which would benefit his venture. Actions by the incoming administration of President Joe Biden, including an executive order aimed at increasing the production of a wide range of goods in domestic factories through Buy American programs, have made him more optimistic.

David Sanford, the brigadier general who directs the supply chain advisory group at the Department of Health and Human Services working on COVID-19 response, has been helping Izhaky and other manufacturers work through the process of getting certified and connected to domestic distributors of medical goods. He said Izhaky’s new factory is exactly the kind of project the U.S. needs to encourage.

“But there’s always a risk,” said Sanford. He adds there are ways the government can support businesses like this, short of giving direct government contracts to purchase goods at higher prices. A requirement to buy U.S.-made protective equipment could be built into Medicare and Medicaid reimbursements, for instance.

Making masks isn’t that hard. The process is highly automated and doesn’t require a costly cleanroom. But getting a dependable supply of the materials, particularly the specialized layers of filtration material that makes them effective, is a challenge.

“You can buy a face mask machine for a few hundred thousand dollars and start it up in 90 days. That’s happening all over the world,” said Sara Greenstein, CEO of Lydall Inc, a U.S. producer of the material that has agreed to supply Izhaky’s operation.

Lydall, aided by federal funds provided early in the crisis, has nearly tripled capacity at its one U.S. plant capable of making the material. With competing Chinese material expected to continue to sell at much lower prices after the pandemic, Lydall CEO Greenstein has “high confidence” there will be government-led programs in the United States and Europe “to buy product made here to help keep that supply chain stable and competitive.”

At the United Safety Technology plant in La Verne, engineers are busy fine tuning the first of the machines that will eventually turn out cup-shaped masks.

Edward Zheng, Izhaky’s partner in the venture, said their goal is to source all the materials domestically, with a key exception: the machines that make the masks in the factory are imported from China.

(Reporting by Timothy Aeppel; editing by Dan Burns and Edward Tobin)

Vaccine passports: path back to normality or problem in the making?

By Natalie Thomas

LONDON (Reuters) – Governments and developers around the world are exploring the potential use of “vaccine passports” as a way of reopening the economy by identifying those protected against the coronavirus.

Those developing the technologies however, say such tools come with consequences such as potentially excluding whole groups from social participation, and are urging lawmakers to think seriously about how they are used.

The travel and entertainment industries, which have struggled to operate at a profit while imposing social distancing regulations, are particularly interested in a way of swiftly checking who has protection.

Among those developing passports are biometrics company iProov and cyber security firm Mvine which have built a vaccine pass now being tested within Britain’s National Health Service after receiving UK government funding.

iProov founder and chief executive Andrew Bud believes such vaccine passports only really need to hold two pieces of information.

“One is, has this person been vaccinated? And the other is, what does this person look like?”

You need only match a face to a vaccination status, you don’t need to know a person’s identity, he added.

Confirmation of patrons’ vaccination status could help the night-time economy, which employs some 420,000 people in the northern English city of Manchester, off its knees, experts say.

“We have to look at how to get back to normal,” said Sacha Lord, an industry adviser and co-founder of the city’s Parklife music festival.

While there have been experiments in socially distanced concerts and events over the last year, they weren’t financially viable, he said.

“A gig isn’t a gig or a festival isn’t a festival unless you are stood shoulder to shoulder with your friends.

“I don’t think we should be forcing people into the vaccine passports. It should be a choice. But on entry, if you don’t have that passport, then we will give you another option,” he added, suggesting the use of rapid result coronavirus tests.

Bud said vaccine certificates were being rolled out in some countries, and in the United Sates, some private sector health passes were being used to admit customers to sports events.

“I think vaccine certificates raise huge social and political issues. Our job is to provide the technology basis for making vaccine passports and certificates possible … It is not our place to make judgments about whether they are a good idea or not,” he said.

Potential issues could arise around discrimination, privilege and exclusion of the younger generation who would be last in line to be vaccinated, he said, adding he believed government was giving it careful consideration.

(Reporting by Natalie Thomas; Writing by Alexandra Hudson; Editing by Mike Collett-White)

Subsiding layoffs raise cautious optimism for U.S. labor market

By Lucia Mutikani

WASHINGTON (Reuters) – The number of Americans filing new applications for unemployment benefits decreased further last week, suggesting the labor market was stabilizing as authorities started to loosen pandemic-related restrictions on businesses.

Despite the signs that layoffs are abating, the weekly jobless claims report from the Labor Department on Thursday showed at least 17.8 million Americans were on benefits in mid-January, indicating that long-term unemployment was likely becoming entrenched. That could boost President Joe Biden’s push for the U.S. Congress to pass his $1.9 trillion recovery plan.

Treasury Secretary Janet Yellen told ABC’s Good Morning America that the massive stimulus plan was needed to overcome the economic pain caused by the COVID-19 pandemic.

“It’s too early to predict that this begins a strong reversal of excruciatingly high layoffs,” said Robert Frick, corporate economist at Navy Federal Credit Union in Vienna, Virginia. “Another round of stimulus is important.”

Initial claims for state unemployment benefits fell 33,000 to a seasonally adjusted 779,000 for the week ended Jan. 30. That was the third straight weekly decline. Economists polled by Reuters had forecast 830,000 applications for the latest week.

Unadjusted claims decreased 23,525 to 816,247 last week. Including a government-funded program for the self-employed, gig workers and others who do not qualify for the regular state unemployment programs, 1.165 million people filed claims last week, down from 1.243 million in the prior period.

Claims remain above their 665,000 peak during the 2007-2009 Great Recession, but well below the record 6.867 million last March when the pandemic hit the United States.

Part of the elevation in claims reflects people re-applying for benefits after the government in late December renewed a $300 unemployment supplement until March 14 as part of a pandemic relief package worth nearly $900 billion.

“The decline in new claims in recent weeks adds to the evidence that the worst months for the labor market could very well be behind us,” said Sarah House, a senior economist at Wells Fargo Securities in Charlotte, North Carolina.

Stocks on Wall Street were trading higher. The dollar rose against a basket of currencies. U.S. Treasury prices were mostly lower.

LAYOFFS SUBSIDING

Though January was the worst month since the onset of the pandemic, the decline in economic activity leveled off in the second half of the month amid signs of a peak in the recent coronavirus wave.

Data from Homebase, a payroll scheduling and tracking company, showed its measure of employees at work flattened out over the last two weeks of January, pausing the decline observed from December into January.

Other data on Thursday from global outplacement firm Challenger, Gray & Christmas showed planned job cuts announced by U.S.-based employers rose only 3.3% to 79,552 in January.

The claims report also showed the number of people receiving benefits after an initial week of aid dropped 193,000 to 4.592 million during the week ended Jan. 23. About 17.836 million people were on unemployment benefits on all programs in mid-January, down from 18.322 million in the first week of 2021.

Last week’s claims data has no bearing on Friday’s closely watched employment report for January, as it falls outside the survey period, which was in the middle of the month. Still, the signs of stability in other labor market measures support expectations that hiring rebounded in January after the economy shed jobs in December for the first time in eight months.

Hopes that the economy created jobs last month were boosted by reports on Wednesday showing rebounds in private payrolls and services industry employment in January. A survey this week also showed manufacturers hired more workers in January.

According to a Reuters poll of economists payrolls likely increased by 50,000 jobs in January after declining by 140,000 in December. In the wake of the fairly upbeat reports, Goldman Sachs lifted its payrolls forecast by 75,000 to 200,000.

But some economists are bracing for a second straight month of job losses in January. The Conference Board’s survey last week showed consumers’ perceptions of labor market conditions deteriorated further last month.

The economy has recouped 12.5 million of the 22.2 million jobs lost in March and April. The Congressional Budget Office estimated on Monday that employment would not return to its pre-pandemic level before 2024.

Economists were unperturbed by a separate report on Thursday from the Labor Department showing worker productivity dropped at a 4.8% annualized rate in the fourth quarter. That was the deepest pace of decline since the second quarter of 1981 and followed a 5.1% pace of expansion in the third quarter. The pandemic has caused wild swings in productivity.

“This decline came after very strong productivity growth in the middle quarters of the year, and we think that the pandemic has led to a shift in economic activity away from some low-productivity sectors that has led to firming in productivity growth through some of the noise in the quarterly readings,” said Daniel Silver, an economist at JPMorgan in New York.

(Reporting by Lucia Mutikani; Editing by Chizu Nomiyama and Paul Simao)

China bat caves need exploring in search for COVID origins, WHO team member says

By David Kirton and David Stanway

WUHAN, China (Reuters) – A member of the World Health Organization-led team searching for clues to the origins of COVID-19 in the central Chinese city of Wuhan said work was needed to try to trace genetic elements of the virus in bat caves.

Peter Daszak, a zoologist and animal disease expert, said the team in Wuhan had been receiving new information about how the virus, first identified in the city in late 2019, led to a pandemic. He did not elaborate but said there was no evidence to suggest it emerged from a lab.

The origin of the coronavirus has become highly politicized following accusations, especially by the United States, that China was not transparent in its early handling of the outbreak. Beijing has pushed the idea that the virus originated elsewhere.

Daszak was involved in research into the origins of Severe Acute Respiratory Syndrome (SARS) in 2002-2003, tracing its roots to bats living in a cave in southwest Yunnan province.

“Similar research needs to be done if we are going to find the true wildlife origin” of COVID-19, said Daszak, president of the New York-based EcoHealth Alliance.

“That sort of work to find the likely bat source is important because if you can find the sources of these lethal viruses you can reduce the contact with those animals,” he told Reuters in an interview.

It is unclear whether China is currently sampling its many bat caves, but viruses similar to SARS-CoV-2 had previously been found in the southwest province of Yunnan.

He said the team in Wuhan had been receiving new information about how the virus led to a pandemic, but did not elaborate.

“I’m seeing a picture coming through of some of the scenarios looking more plausible than before,” he said.

One scenario being scrutinized more closely by the team is the possibility that the virus could have been circulating long before it was first identified in Wuhan.

“That’s something our group is looking at very intensely to see what level of community transmission could have been happening earlier,” Daszak said.

“The real work we are doing here is to trace back from the first cases back to an animal reservoir, and that’s a much more convoluted path, and may have happened over a number of months or even years.”

The investigators have visited hospitals, research facilities and the seafood market where the first outbreak was identified, although their contacts in Wuhan are limited to visits organized by their Chinese hosts.

Daszak said Chinese authorities had not refused any of the team’s requests to visit facilities or meet with key figures.

“It is of course impossible to know what you are not being told, but what I am seeing in China, and what this group is seeing in China, is that what we asked for, we are being allowed to do,” Daszak said.

(Reporting by David Stanway in Shanghai and David Kirton in Wuhan; Editing by Nick Macfie)